Developing Strategies for Landscape Sustainability: An Indonesian National Strategic Plan of Action in the Heart of Borneo

2017 ◽  
pp. 67-84
Author(s):  
Rachmad Firdaus ◽  
Prabianto Mukti Wibowo ◽  
Yanto Rochmayanto
Keyword(s):  
Strategic Plan ◽  
Landscape Sustainability ◽  
National Strategic Plan ◽  
Developing Strategies

scholarly journals Prioritising CAP Intervention Needs: An Improved Cumulative Voting Approach

2021 ◽  
Vol 13 (7) ◽  
pp. 3997
Author(s):  
Roberto Cagliero ◽  
Francesco Bellini ◽  
Francesco Marcatto ◽  
Silvia Novelli ◽  
Alessandro Monteleone ◽  
...  
Keyword(s):  
Decision Making ◽  
Planning Process ◽  
Strategic Plan ◽  
Evidence Based ◽  
Agricultural Activities ◽  
Agriculture Policy ◽  
Implementation Model ◽  
National Strategic Plan ◽  
Cumulative Voting ◽  
Regional Authorities

The process to define the 2023–2027 Common Agriculture Policy (CAP) is underway. The implementation model governing the process requires each EU Member State to design a National Strategic Plan to deliver operational actions exploiting the synergies under the two pillars of the policy. Each Plan must be built from an evidence-based needs assessment that undergoes rigorous prioritisation and planning to create comprehensive, integrated, and achievable interventions. In Italy, the success of this planning process requires all interested stakeholders to generate options for the regional authorities who plan, manage, and legislate agricultural activities. This research proposes a decision-making technique, based on the cumulative voting approach, that can be used effectively when multiple persons from different backgrounds and perspectives are engaged in problem-solving and needs prioritisation. The results indicate that the model can be applied both theoretically and practically to prioritise Strategic Plan needs that involve national and regional authorities. Validation of the model allows it to be used in the next consultative processes and for expansion to socioeconomic stakeholders.

scholarly journals Achieving the National Strategic Plan: A practical calculator for local target setting in district health facilities

2010 ◽  
Vol 100 (7) ◽  
pp. 420 ◽  
Author(s):  
Nicholas G Leydon ◽  
Francois Venter ◽  
Patricia D Webster ◽  
Winnie Moleko ◽  
Regina Osih ◽  
...  
Keyword(s):  
Strategic Plan ◽  
Health Facilities ◽  
District Health ◽  
Target Setting ◽  
National Strategic Plan

Pilot Study on non-tuberculous mycobacteria infections in Italy

2020 ◽  
Vol 30 (Supplement_5) ◽  
Author(s):  
L Fattorini ◽  
A Iacobino ◽  
F Giannoni ◽  
Keyword(s):  
Cystic Fibrosis ◽  
Minimum Inhibitory Concentration ◽  
Pilot Study ◽  
Inhibitory Concentration ◽  
Strategic Plan ◽  
Foreign Born ◽  
Old Patients ◽  
National Strategic Plan ◽  
Reported Data ◽  
Resistance Rates

Abstract Background The rise in non-tuberculous mycobacteria (NTM) diseases has been reported worldwide, but no major information is known for Italy. The purpose of this pilot study is to release nationwide data on distribution of NTM in our country. Methods In 2016, the Istituto Superiore di Sanità (National Institute of Health) began to collect microbiological, clinical and minimum inhibitory concentration (MIC) data on NTM infections, in collaboration with hospital laboratories located in 15 out of 20 regions (Studio Multicentrico Italiano NTM, SMI-NTM), which routinely isolate and characterize NTM by commercial identification (Genotype) and MIC (Sensititre) assays. Results In 2016-2018, 32 labs reported data on 4169 NTM strains, including 644 rapid growers (15%) and 3525 slow growers (85%). The most frequent species were Mycobacterium avium (MA) (29.2%), M. intracellulare (MI) (21.5%), M. xenopi (MX) (10.6%), M. gordonae (10.6%), M. abscessus (5.9%), M. chimaera (MC) (5.1%). Overall, 88% NTM strains were isolated from pulmonary sites, 84% from Italians, 51% from men. NTM infections in Italians occurred in 75-84 years old patients, while in foreign-born people were observed in 15-44 years old patients. Strains from cystic fibrosis were 11.9%. The MICs of clarithromycin (CLA) for MA or MI peaked at 2 µg/ml, while for amikacin (AK) peaked at 16 µg/ml. When MICs were interpreted according to the 2018 Clinical and Laboratory Institute Standards (CLSI) breakpoints, MA or MI resistances for CLA were 2.6% and 2.6% respectively, while for AK they were 7.2% and 4.5%, respectively. Higher resistance rates for MA and MI were observed for moxifloxacin and linezolid. MICs of MC, MX, M. kansasii, M. marinum and rapid grower NTM were also determined and interpreted on the basis of CLSI breakpoints. Conclusions This 3-years pilot study is the basis for a future multiannual national strategic plan for surveillance of NTM infections in Italy (collection of 2019 data is in progress). Key messages This 3-years pilot study is the basis for a future multiannual national strategic plan for surveillance of NTM infections in Italy. The purpose of this pilot study is to release nationwide data on distribution of NTM in our country.

Adoption of One Health in Thailand’s National strategic plan for emerging infectious diseases

2016 ◽  
Vol 38 (1) ◽  
pp. 121-136 ◽  
Author(s):  
Angkana Sommanustweechai ◽  
Sopon Iamsirithaworn ◽  
Walaiporn Patcharanarumol ◽  
Wantanee Kalpravidh ◽  
Viroj Tangcharoensathien
Keyword(s):  
Infectious Diseases ◽  
One Health ◽  
Emerging Infectious Diseases ◽  
Strategic Plan ◽  
National Strategic Plan

scholarly journals The second strategic plan of medical ethics: a national report

2022 ◽  
Author(s):  
Alireza Parsapour ◽  
Ehsan Shamsi Gooshki ◽  
Hossein Malekafzali ◽  
Farzaneh Zahedi ◽  
Bagher Larijani
Keyword(s):  
Medical Ethics ◽  
Clinical Medicine ◽  
Group Discussion ◽  
Strategic Plan ◽  
Comprehensive Plan ◽  
System A ◽  
National Strategic Plan ◽  
National Report ◽  
Supreme Council ◽  
Research And Education

Medical ethics faces several challenges in different aspects of education, research, and treatment in medicine and healthcare practice. Design and implementation of a national strategic plan can pave the way for the development of a roadmap in various countries to strengthen ethics and address these challenges.  To create a comprehensive plan compatible with the Iranian healthcare system, a multidisciplinary team of main stakeholders compiled a national strategic plan of medical ethics following several focus group discussion sessions and two workshops (2014-2017). Ultimately, the plan was confirmed by the Supreme Council for the Medical Ethics of the Ministry of Health and Medical Education. The current paper is a national report of the process and the medical ethics strategic plan in Iran. We have also tracked signs of progress and achievements in the country. In conclusion, this valuable effort has led to significant success in the implementation of medical ethics in clinical medicine, medical research, and education by using all the resources in our country. The participation of all the stakeholders, especially healthcare professionals in this way is required.  

scholarly journals Current situation of tuberculosis and National Strategic Plan for Tuberculosis Control in Korea

2021 ◽  
Vol 64 (4) ◽  
pp. 316-323
Author(s):  
Eunjeong Son ◽  
Doosoo Jeon
Keyword(s):  
Insurance Coverage ◽  
Public Health Problem ◽  
Strategic Plan ◽  
Multidrug Resistant ◽  
High Rate ◽  
Foreign Born ◽  
Tuberculosis Control ◽  
Notification Rate ◽  
Tb Control ◽  
National Strategic Plan

Tuberculosis (TB) remains a serious public health problem in Korea. Korea has the highest incidence rate (59 per 100,000 population) and the second-highest TB mortality rate (four per 100,000 population) among Organisation for Economic Cooperation and Development member countries. However, some progress has been made in TB control over the past decade. The notification rate of new TB cases has been gradually decreasing since reaching its highest rate in 2011 (78.9 per 100,000 population). In 2019, the notification rate of new TB cases was 46.4 per 100,000 population, with a reduction of 9.9% from the 2018 rate. Additionally, the number of multidrug-resistant TB cases decreased from 618 in 2018 to 580 in 2019. This progress is thought the result of various TB control programs including a TB public–private mix model, insurance coverage for TB management, and a contact investigation program. Despite the progress made, new challenges have also emerged. The predominant challenges lie in the relatively increasing burden of TB in the vulnerable population (aging, socio-economically vulnerable, and foreign-born population), the implementation of latent TB infection management, and the high rate of multidrug-resistant TB. Since 2019, the Korean government has been implementing the “Midterm strategies to strengthen TB prevention and management” based on the 2nd National Strategic Plan for Tuberculosis Control (2018-2022). This program will be a turning point of TB control in Korea. The results produced in 2023 is expected to be favorable.

Sign in / Sign up

Export Citation Format

Share Document